COMP <GO>
VTRS vs LLY // 10Y YIELD & FRED MACRO BETA
Viatris Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: VTRS 2
— LLY 12
▲ 10Y YIELD & FRED MACRO BETA LEADER: VTRS
LAST: $19.04 (-0.83%) • MKT CAP: $22.05B
macro-sensitivity
1.15
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
macro-sensitivity
0.51
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VTRS VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VTRS | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.20% | 83.64% | -48.44 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -8.10% | 32.36% | -40.46 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 36.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 8.78% | 2.30% | +6.48 | VTRS | /fcf-yield <GO> |
| Operating Margin | -18.70% | 40.21% | -58.91 | LLY | /operating-margins <GO> |
| Net Profit Margin | -14.60% | 31.90% | -46.50 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | -3.00% | 45.51% | -48.51 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.81 | 9.29 | -8.48 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.77% | +0.63 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.1 | 77.9 | -13.74 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.15 | 0.51 | +0.64 | VTRS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.0x | 26.3x | +6.75 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.05B | $1.33T | -$1.31T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VTRS REV | LLY REV | VTRS GROSS % | LLY GROSS % | VTRS FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $14.25B | $65.18B | 35.2% | 83.0% | $1.94B | $16.81B |
| FY 2024 | $14.69B | $45.04B | 38.3% | 81.3% | $1.98B | $8.82B |
| FY 2023 | $15.39B | $34.12B | 44.0% | 79.3% | $2.21B | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VTRS // BETA 1.15
LLY // BETA 0.51